Skip to search.
 STI Up 0.09%

Galena Biopharma, Inc. (GALE)

-NasdaqCM
1.70 Up 0.09(5.45%) 21:33 SGT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:1.61
Open:N/A
Bid:1.70 x 3400
Ask:1.71 x 1000
1y Target Est:4.38
Beta:0.46
Next Earnings Date: 6-Aug-15GALE Earnings announcement
Day's Range:1.66 - 1.70
52wk Range:1.27 - 3.16
Volume:200,500
Avg Vol (3m):3,169,990
Market Cap:274.54M
P/E (ttm):N/A
EPS (ttm):-0.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GALEUp 5.45%274.54M
CELGUp 0.50%107.95B
VSTMUp 0.92%281.33M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):26.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.33
Quarterly EPS Est (Jun-15) :-0.09
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs across cancer care. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback